LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
Position in ABT — Abbott Laboratories
CIK 932974
BOSTON, MA
Position in ABT
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$142,115,716
-$23,598,692 QoQ
Shares Held
1,566,186
-3.0% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
1.39%
of 13F equity value
Holder Rank
#99
of 2,959 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 3%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $508,643,239 across 9 Medical Devices names. ABT ranks #2 (27.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
1,154,957 | $363,626,661 | |
| 2 | ABT |
Abbott Laboratories
This page
|
1,566,186 | $142,115,716 | |
| 3 | EW |
Edwards Lifesciences Corp
|
27,447 | $2,482,854 | |
| 4 | PODD |
Insulet Corp
|
1,000 | $152,250 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
1,523 | $97,487 | |
| 6 | MDT |
Medtronic plc
|
975 | $76,274 | |
| 7 | BSX |
Boston Scientific Corp
|
1,233 | $52,624 | |
| 8 | PEN |
Penumbra Inc
|
105 | $33,153 |
All Filings in ABT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $142,115,716 | 1,566,186 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $165,714,408 | 1,614,049 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $206,323,811 | 1,646,770 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $223,652,206 | 1,669,794 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $229,145,566 | 1,684,770 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $225,355,502 | 1,698,873 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $194,969,967 | 1,723,720 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $197,211,988 | 1,729,778 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $181,109,726 | 1,742,948 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $198,424,671 | 1,745,774 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $193,504,268 | 1,758,011 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $170,967,076 | 1,765,277 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $193,957,480 | 1,779,100 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $180,298,694 | 1,780,552 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $196,231,398 | 1,787,334 | Shares | Sole | 2023-03-02 | |
| 2022-09-30 | $174,022,375 | 1,798,495 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $195,643,989 | 1,800,681 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $214,118,210 | 1,809,042 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $257,913,930 | 1,832,556 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $216,599,505 | 1,833,569 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $212,194,213 | 1,830,365 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $216,319,707 | 1,805,071 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $200,173,887 | 1,828,239 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $198,540,418 | 1,824,317 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $167,427,255 | 1,831,207 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $145,814,789 | 1,847,862 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||